239 related articles for article (PubMed ID: 27793758)
21. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
Baviskar D; Sharma R; Jain D
Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
[TBL] [Abstract][Full Text] [Related]
22. [Preparation and release mechanism of gestodene reservoir-type intravaginal rings].
Li CX; Wang YK; Ning MY
Yao Xue Xue Bao; 2014 Mar; 49(3):399-405. PubMed ID: 24961114
[TBL] [Abstract][Full Text] [Related]
23. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
[TBL] [Abstract][Full Text] [Related]
24. Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings.
Malcolm K; Woolfson D; Russell J; Tallon P; McAuley L; Craig D
J Control Release; 2003 Jun; 90(2):217-25. PubMed ID: 12810304
[TBL] [Abstract][Full Text] [Related]
25. Controlled delivery of the antiprotozoal agent (tinidazole) from intravaginal polymer matrices for treatment of the sexually transmitted infection, trichomoniasis.
Fernando HV; Chan LL; Dang N; Santhanes D; Banneheke H; Nalliah S; Coombes AGA
Pharm Dev Technol; 2019 Mar; 24(3):348-356. PubMed ID: 29799300
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the resistance of a geopolymer-based drug delivery system to tampering.
Cai B; Engqvist H; Bredenberg S
Int J Pharm; 2014 Apr; 465(1-2):169-74. PubMed ID: 24556174
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic evaluation of binary effects of magnesium stearate and talc as dissolution retardants at 85% drug loading in an experimental extended-release formulation.
Dürig T; Fassihi R
J Pharm Sci; 1997 Oct; 86(10):1092-8. PubMed ID: 9344163
[TBL] [Abstract][Full Text] [Related]
28. Suitability of Gelucire 50/13 for controlled release formulation of salbutamol sulphate.
Mohsin S; Rahman NU; Idrees MA; Sarfraz MK; Khan MK; Mustafa G
Pak J Pharm Sci; 2012 Jan; 25(1):35-41. PubMed ID: 22186307
[TBL] [Abstract][Full Text] [Related]
29. Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin.
Tajiri T; Morita S; Sakamoto R; Mimura H; Ozaki Y; Reppas C; Kitamura S
Int J Pharm; 2015 Jul; 490(1-2):368-74. PubMed ID: 26022889
[TBL] [Abstract][Full Text] [Related]
30. Characterisation of protein stability in rod-insert vaginal rings.
Pattani A; Lowry D; Curran RM; McGrath S; Kett VL; Andrews GP; Malcolm RK
Int J Pharm; 2012 Jul; 430(1-2):89-97. PubMed ID: 22486955
[TBL] [Abstract][Full Text] [Related]
31. An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems.
Jug M; Hafner A; Lovrić J; Kregar ML; Pepić I; Vanić Ž; Cetina-Čižmek B; Filipović-Grčić J
J Pharm Biomed Anal; 2018 Jan; 147():350-366. PubMed ID: 28720350
[TBL] [Abstract][Full Text] [Related]
32. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R
Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471
[TBL] [Abstract][Full Text] [Related]
33. Sustained release of the candidate antiretroviral peptides T-1249 and JNJ54310516-AFP from a rod insert vaginal ring.
Murphy DJ; Amssoms K; Pille G; Clarke A; O'Hara M; van Roey J; Malcolm RK
Drug Deliv Transl Res; 2016 Jun; 6(3):234-42. PubMed ID: 26787615
[TBL] [Abstract][Full Text] [Related]
34. Simulating Different Dosing Scenarios for a Child-Appropriate Valproate ER Formulation in a New Pediatric Two-Stage Dissolution Model.
Karkossa F; Krueger A; Urbaniak J; Klein S
AAPS PharmSciTech; 2017 Feb; 18(2):309-316. PubMed ID: 27909943
[TBL] [Abstract][Full Text] [Related]
35. Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method.
Qiu Y; Garren J; Samara E; Cao G; Abraham C; Cheskin HS; Engh KR
J Pharm Sci; 2003 Nov; 92(11):2317-25. PubMed ID: 14603516
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer treatment with a locally insertable controlled release delivery system.
Keskar V; Mohanty PS; Gemeinhart EJ; Gemeinhart RA
J Control Release; 2006 Oct; 115(3):280-8. PubMed ID: 17034891
[TBL] [Abstract][Full Text] [Related]
37. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
[TBL] [Abstract][Full Text] [Related]
38. Characterization of anastrozole effects, delivered by an intravaginal ring in cynomolgus monkeys.
Rotgeri A; Korolainen H; Sundholm O; Schmitz H; Fuhrmann U; Prelle K; Sacher F
Hum Reprod; 2015 Feb; 30(2):308-14. PubMed ID: 25432919
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
[TBL] [Abstract][Full Text] [Related]
40. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
